Dr. Delaloge is a medical oncologist. She trained in France and Canada. She has been Head of the Breast Cancer Department at Gustave Roussy, Paris, France since 2004 and currently leads a multidisciplinary team of 70 doctors, caregivers and researchers, coordinating and managing all clinical and clinical research activities.

Dr. Delaloge’s major areas of expertise and development are precision risk-based cancer prevention, precision oncology and the organization of care in breast oncology. She has been investigator, principal investigator, national or international coordinator of more than 120 clinical trials over the last 20 years. She has been chair of the French National Breast Cancer Research Intergroup UCBG, until May 2019. She chairs the large H2020 EU-funded MyPeBS project and clinical trial, which aims at demonstrating the value of risk-based breast cancer screening among 85000 women randomized in 5 European countries, with the participation of 26 European and American partners.

Dr. Delaloge is the author of more than 220 international peer-reviewed publications and more than 500 presentations at international conferences (Google Scholar H-Index: 60). She is a board member of the European Society of Medical Oncology (ESMO) and of the French Society of Breast Care and Breast Pathology, and a member of the American Society of Clinical Oncology (ASCO) and participates to the elaboration of numerous national and international guidelines.

Dr. Delaloge is breast specialty editor for European Journal of Cancer and genetics editor for The Breast, a member of the international advisory board of The Lancet Oncology. Dr. Delaloge is committed to numerous continuous teaching activities dedicated to doctors in training and medical students.